pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2013-0-6-72-78pulmo-311Research ArticleОБЗОРЫREVIEWСвязь аллергических заболеваний с аутоиммунитетомRelationships between allergic disease and autoimmunityГервазиеваВ. Б.GervazievaV. B.

д. м. н., профессор, зав. отделом аллергологии 

105063, Москва, М. Казенный пер., 5а. Тел. / факс: (495) 917-20-26.

vbger@mail.ruСверановскаяВ. В.SveranovskayaV. V.

к. м. н., ведущий научный сотрудник лаборатории аллергодиагностики

105063, Москва, М. Казенный пер., 5а. Тел.: (495) 917-20-26.

svervv@rambler.ruКонищеваА. Ю.KonishchevaA. Yu.

к. м. н., ст. научный сотрудник лаборатории аллергодиагностики 

105063, Москва, М. Казенный пер., 5а. Тел.: (495) 917-20-26.

ankon81@list.ruФГБУ "НИИ вакцин и сывороток им. И.И.Мечникова" РАМНRussian Federation201328122013067278Copyright © Гервазиева В.Б., Сверановская В.В., Конищева А.Ю., 20132013Гервазиева В.Б., Сверановская В.В., Конищева А.Ю.Gervazieva V.B., Sveranovskaya V.V., Konishcheva A.Y.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/311

Связь аллергических заболеваний с аутоиммунитетом.

Relationships between allergic disease and autoimmunity.

атопияаутоиммунитетаутоантителаастмаIgE-реактивностьТh- и Treg-клеткиatopyautoimmunityautoantibodiesashmaIgE-reactivityTh- and Treg-cellsReferencesSheikh A., Smeeth L., Hubbard R. There is no evidence of an inverse relationship between Th2-mediated atopy and Th1- mediated autoimmune disorders: lack of support for the hygiene hypothesis. J. Allergy Clin. Immunol. 2003; 111 (1): 131–135.Sheikh A., Smeeth L., Hubbard R. There is no evidence of an inverse relationship between Th2-mediated atopy and Th1- mediated autoimmune disorders: lack of support for the hygiene hypothesis. J. Allergy Clin. Immunol. 2003; 111 (1): 131–135.Guo J., Rapoport B., McLachlan S.M. Thyroid peroxidase autoantibodies of IgE class in Thyroid autoimmunity. Clin. Immunol. Immunopathol. 1997; 82 (2): 157–162.Guo J., Rapoport B., McLachlan S.M. Thyroid peroxidase autoantibodies of IgE class in Thyroid autoimmunity. Clin. Immunol. Immunopathol. 1997; 82 (2): 157–162.Воробьева Н.Л., Гервазиева В.Б. Соотношение Th1 и Th2-опосредованного иммунного ответа у детей с вирусными энцефалитами. Russ. J. Immunol. 2001; 6 (4): 383–392.Воробьева Н.Л., Гервазиева В.Б. Соотношение Th1 и Th2-опосредованного иммунного ответа у детей с вирусными энцефалитами. Russ. J. Immunol. 2001; 6 (4): 383–392.Демкина В.А., Воробьева Н.Л., Шабалина С.В., Гервазиева В.Б. Современные аспекты проблемы вирусных энцефалитов. Сообщение 1. Развитие аутоиммунного демиелинизирующего процесса в ЦНС при вирусных энцефалитах. Инфекц. бол. 2005; 3 (2): 66–70.Демкина В.А., Воробьева Н.Л., Шабалина С.В., Гервазиева В.Б. Современные аспекты проблемы вирусных энцефалитов. Сообщение 1. Развитие аутоиммунного демиелинизирующего процесса в ЦНС при вирусных энцефалитах. Инфекц. бол. 2005; 3 (2): 66–70.Potena A., La Corte R., Fabbri L.M. et al. Increased bronchial responsiveness in primary and secondary Sjogren's syndrome. Eur. Respir. J. 1990; 3 (5): 548–553.Potena A., La Corte R., Fabbri L.M. et al. Increased bronchial responsiveness in primary and secondary Sjogren's syndrome. Eur. Respir. J. 1990; 3 (5): 548–553.Hassan W.U., Keaney N.P., Hollan C.D., Kelly C.A. Bronchial reactivity and airflow obstruction in rheumatoid arthritis. Ann. Rheum. Dis. 1994; 53 (8): 511–514.Hassan W.U., Keaney N.P., Hollan C.D., Kelly C.A. Bronchial reactivity and airflow obstruction in rheumatoid arthritis. Ann. Rheum. Dis. 1994; 53 (8): 511–514.La Corte R., Bajocchi G., Potena A. et al. Bronchial hyperreactivity in systemic sclerosis patients: influence of associated Sjogren's syndrome. Ann. Rheum. Dis. 1995; 54 (8): 636–639.La Corte R., Bajocchi G., Potena A. et al. Bronchial hyperreactivity in systemic sclerosis patients: influence of associated Sjogren's syndrome. Ann. Rheum. Dis. 1995; 54 (8): 636–639.Amin K., Ludviksdottir D., Janson C. et al. Bronchial hyperresponsiveness. Inflammation and structural changes in the airways of patients with primary Sjogren's syndrome. Respir. Med. 2001; 95 (11): 904–910.Amin K., Ludviksdottir D., Janson C. et al. Bronchial hyperresponsiveness. Inflammation and structural changes in the airways of patients with primary Sjogren's syndrome. Respir. Med. 2001; 95 (11): 904–910.Greaves M.W. Chronic urticaria. J. Allergy Clin. Immunol. 2000; 105 (4): 664–672.Greaves M.W. Chronic urticaria. J. Allergy Clin. Immunol. 2000; 105 (4): 664–672.Stitt J.M., Dreskin S.C. Urticaria and autoimmunity: where are we now? Curr. Allergy Asthma Rep. 2013; 13 (5): 555–562. DOI 10.1007/s 11882-013-0366-8Stitt J.M., Dreskin S.C. Urticaria and autoimmunity: where are we now? Curr. Allergy Asthma Rep. 2013; 13 (5): 555–562. DOI 10.1007/s 11882-013-0366-8Konstantinou G.N., Asero R., Ferrer M. et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy 2013; 68 (1): 27–36.Konstantinou G.N., Asero R., Ferrer M. et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy 2013; 68 (1): 27–36.Comi A.L., Tedeschi A., Lorini M., Miadonna A. Novel clinical and serological aspects in non-allergic asthma. Respir. Med. 2007; 101 (12): 2526–2533.Comi A.L., Tedeschi A., Lorini M., Miadonna A. Novel clinical and serological aspects in non-allergic asthma. Respir. Med. 2007; 101 (12): 2526–2533.Tedeschi A., Asero R. Asthma and autoimmunity: a complex but intriguing relation. Expert Rev. Clin. Immunol. 2008; 4 (6): 767–776.Tedeschi A., Asero R. Asthma and autoimmunity: a complex but intriguing relation. Expert Rev. Clin. Immunol. 2008; 4 (6): 767–776.Konischeva A.Y., Gervazieva V.B. Autoantibodies and cytokines in bronchial asthma. In: International Proceeding WCA. Monaco: Mediamond, 2008. 163–167.Konischeva A.Y., Gervazieva V.B. Autoantibodies and cytokines in bronchial asthma. In: International Proceeding WCA. Monaco: Mediamond, 2008. 163–167.Valenta R., Maurer D., Steiner R. et al. Immunoglobulin E response to human proteins in atopic patients. J. Invest. Dermatol. 1996; 107: 203–208.Valenta R., Maurer D., Steiner R. et al. Immunoglobulin E response to human proteins in atopic patients. J. Invest. Dermatol. 1996; 107: 203–208.Natter S., Seiberler S., Hufnagl P. et al. Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients. FASEB J. 1998; 12: 1559–1569.Natter S., Seiberler S., Hufnagl P. et al. Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients. FASEB J. 1998; 12: 1559–1569.Seiberler S., Natter S., Hufnagl P. et al. Characterization of IgE-reactive autoantigens in atopic dermatitis. 2. A pilot study on IgE versus IgG subclass response and seasonal variation of IgE autoreactivity. Int. Arch. Allergy Immunol. 1999; 120 (2): 117–125.Seiberler S., Natter S., Hufnagl P. et al. Characterization of IgE-reactive autoantigens in atopic dermatitis. 2. A pilot study on IgE versus IgG subclass response and seasonal variation of IgE autoreactivity. Int. Arch. Allergy Immunol. 1999; 120 (2): 117–125.Altrichter S., Kriehuber E., Moser J. et al. Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis. J. Invest. Dermatol. 2008; 128: 2232–2239.Altrichter S., Kriehuber E., Moser J. et al. Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis. J. Invest. Dermatol. 2008; 128: 2232–2239.Sugiura K., Muro Y., Nishizava Y. et al. LEDGF/DFS70, a major autoantigen of atopic dermatitis, is a component of keratohyalin granules. J. Invest. Dermatol. 2007; 127 (1): 75–80.Sugiura K., Muro Y., Nishizava Y. et al. LEDGF/DFS70, a major autoantigen of atopic dermatitis, is a component of keratohyalin granules. J. Invest. Dermatol. 2007; 127 (1): 75–80.Watanabe K., Muro Y., Sugiura K., Tomita Y. IgE and IgG(4) autoantibodies against DFS70/LEDGF in atopic dermatitis. Autoimmunity 2011; 44 (6): 511–519.Watanabe K., Muro Y., Sugiura K., Tomita Y. IgE and IgG(4) autoantibodies against DFS70/LEDGF in atopic dermatitis. Autoimmunity 2011; 44 (6): 511–519.Самойликов П.В., Гервазиева В.Б., Кожевников С.А. IgE- и IgG-аутореактивность у детей с атопическим дерматитом. Рос. вестн. перинатол. и педиатр. 2012; 1: 97–102.Самойликов П.В., Гервазиева В.Б., Кожевников С.А. IgE- и IgG-аутореактивность у детей с атопическим дерматитом. Рос. вестн. перинатол. и педиатр. 2012; 1: 97–102.Bieber T., Novak N. New concepts of atopic dermatitis. From non-IgE-mediated via IgE-mediated to autoimmune inflammation. Allergy Clin. Immunol. Int. J. World Allergy Org. 2005; 17: 26–29.Bieber T., Novak N. New concepts of atopic dermatitis. From non-IgE-mediated via IgE-mediated to autoimmune inflammation. Allergy Clin. Immunol. Int. J. World Allergy Org. 2005; 17: 26–29.Bar7Sela S., Reshef T., Mekori YA. IgE antithyroid microsomal antibodies in patient with chronic urticaria. J. Allergy Clin. Immunol. 1999; 103: 1216–1217.Bar7Sela S., Reshef T., Mekori YA. IgE antithyroid microsomal antibodies in patient with chronic urticaria. J. Allergy Clin. Immunol. 1999; 103: 1216–1217.Sibgatulina N.A., Kuz'mina N.S., Rakhmatullina N.M., Gervazieva V.B. Autoantibodies to thyroid gland antigens in chronic relapsing urticaria. Zh. Mikrobiol. Epidemiol. Immunobiol. 2002; 5: 69–71.Sibgatulina N.A., Kuz'mina N.S., Rakhmatullina N.M., Gervazieva V.B. Autoantibodies to thyroid gland antigens in chronic relapsing urticaria. Zh. Mikrobiol. Epidemiol. Immunobiol. 2002; 5: 69–71.Tedeschi A., Lorini M., Asero R. Anti-thyroid peroxidase IgE in patients with chronic urticaria. J. Allergy Clin. Immunol. 2001; 108 (3): 467–468.Tedeschi A., Lorini M., Asero R. Anti-thyroid peroxidase IgE in patients with chronic urticaria. J. Allergy Clin. Immunol. 2001; 108 (3): 467–468.Altrichter S., Peter H.7J., Pisarevskaja D. et al. IgE mediated autoallergy against thyroid peroxidase – A novel pathomechanism of chronic spontaneous urticaria? PLos One. 2011; 6 (4): e14794.Altrichter S., Peter H.7J., Pisarevskaja D. et al. IgE mediated autoallergy against thyroid peroxidase – A novel pathomechanism of chronic spontaneous urticaria? PLos One. 2011; 6 (4): e14794.Concha L.B., Chang C.C., Szema A.M. et al. IgE antithyroid antibodies in patients with Hashimoto's disease and chronic urticaria. Allergy Asthma Proc. 2004; 25 (5): 293–296.Concha L.B., Chang C.C., Szema A.M. et al. IgE antithyroid antibodies in patients with Hashimoto's disease and chronic urticaria. Allergy Asthma Proc. 2004; 25 (5): 293–296.Fekri M.S., Shokoochi M., Gozashti M.7H. et al. Association between anti-thyroid peroxidase antibody and asthma in women. Iran J. Allergy Asthma Immunol. 2012; 11 (3): 241–245.Fekri M.S., Shokoochi M., Gozashti M.7H. et al. Association between anti-thyroid peroxidase antibody and asthma in women. Iran J. Allergy Asthma Immunol. 2012; 11 (3): 241–245.Pedulla M., Miraglia Del Giudice M., Fierro V. et al. Atopy as a risk factor for thyroid autoimmunity in children. J. Biol. Regul. Homeost. Agents 2012; 26 (Suppl. 1): 9–14.Pedulla M., Miraglia Del Giudice M., Fierro V. et al. Atopy as a risk factor for thyroid autoimmunity in children. J. Biol. Regul. Homeost. Agents 2012; 26 (Suppl. 1): 9–14.Pedulla M., Papacciuolo V., Alfano R., Ruocco E. Atopy as a risk factor for thyroid autoimmunity in children affected with atopic dermatitis. J. Eur. Acad. Dermatol.Venereol. 2013; doi: 10. 1111/jdv. 12281.Pedulla M., Papacciuolo V., Alfano R., Ruocco E. Atopy as a risk factor for thyroid autoimmunity in children affected with atopic dermatitis. J. Eur. Acad. Dermatol.Venereol. 2013; doi: 10. 1111/jdv. 12281.Lassalle P., Delneste Y., Gosset P. et al. T and B cell response to a 55-kDa endothelial cell-derived antigen in severe asthma. Eur. J. Immunol. 1993; 23 (4): 796–803.Lassalle P., Delneste Y., Gosset P. et al. T and B cell response to a 55-kDa endothelial cell-derived antigen in severe asthma. Eur. J. Immunol. 1993; 23 (4): 796–803.Nahm D.7H., Lee Y.E., Yim E.7J. et al. Identification of cytokeratin 18 as a bronchial epithelial autoantigen associated with nonallergic asthma. Am. J. Respir. Crit. Care Med. 2002; 165: 1536–1539.Nahm D.7H., Lee Y.E., Yim E.7J. et al. Identification of cytokeratin 18 as a bronchial epithelial autoantigen associated with nonallergic asthma. Am. J. Respir. Crit. Care Med. 2002; 165: 1536–1539.Nahm D.7H., Lee Y.E., Shin J.7Y. et al. Identification of α-enolase as an autoantigen associated with severe asthma. J. Allergy Clin. Immunol. 2006; 118: 376–381.Nahm D.7H., Lee Y.E., Shin J.7Y. et al. Identification of α-enolase as an autoantigen associated with severe asthma. J. Allergy Clin. Immunol. 2006; 118: 376–381.Liu M., Subramanian V., Christie Ch. et al. Immune responses to self-antigens in asthma patients: Clinical and immune-pathological implications. Hum. Immunol. 2012; 73 (5): 511–516.Liu M., Subramanian V., Christie Ch. et al. Immune responses to self-antigens in asthma patients: Clinical and immune-pathological implications. Hum. Immunol. 2012; 73 (5): 511–516.Inganas M., Johansson S.G., Bennich H. Anti-IgE antibodies in human serum: occurrence and specificity. Int. Arch. Allergy Appl. Immunol. 1981; 65 (1): 51–61.Inganas M., Johansson S.G., Bennich H. Anti-IgE antibodies in human serum: occurrence and specificity. Int. Arch. Allergy Appl. Immunol. 1981; 65 (1): 51–61.Lotvall J., Akdis C.A., Bacharier L.B. et al. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome. J. Allergy Clin. Immunol. 2011; 127 (2): 355–360.Lotvall J., Akdis C.A., Bacharier L.B. et al. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome. J. Allergy Clin. Immunol. 2011; 127 (2): 355–360.Wenzel S. Asthma phenotypes: the evolution from clinical to molecular approaches. Nature Med. 2012; 18 (5): 716–725.Wenzel S. Asthma phenotypes: the evolution from clinical to molecular approaches. Nature Med. 2012; 18 (5): 716–725.Garn H., Mittermann I., Valenta R., Renz H. Autosensitization as a pathomechanism in asthma. Ann. N.Y. Acad. Sci. 2007; 1107: 417–425.Garn H., Mittermann I., Valenta R., Renz H. Autosensitization as a pathomechanism in asthma. Ann. N.Y. Acad. Sci. 2007; 1107: 417–425.Bunder R., Mittermann I., Herz U. et al. Induction of autoallergy with an environmental allergen mimicking a self protein in a murine model of experimental allergic asthma. J. Allergy Clin. Immunol. 2004; 114: 422–428.Bunder R., Mittermann I., Herz U. et al. Induction of autoallergy with an environmental allergen mimicking a self protein in a murine model of experimental allergic asthma. J. Allergy Clin. Immunol. 2004; 114: 422–428.Seiberler S., Bugajska7Schretter A., Hufnagl P. et al. Characterization of IgE-reactive autoantigens in atopic dermatitis. 1. Subcellular distribution and tissue-specific expression. Int. Arch. Allergy Immunol. 1999; 120 (2): 108–116.Seiberler S., Bugajska7Schretter A., Hufnagl P. et al. Characterization of IgE-reactive autoantigens in atopic dermatitis. 1. Subcellular distribution and tissue-specific expression. Int. Arch. Allergy Immunol. 1999; 120 (2): 108–116.Crameri R., Faith A., Hemmann S. et al. Humoral and cellmediated autoimmunity in allergy to Aspergillus fumigatus. J. Exp. Med. 1996; 184: 265–270.Crameri R., Faith A., Hemmann S. et al. Humoral and cellmediated autoimmunity in allergy to Aspergillus fumigatus. J. Exp. Med. 1996; 184: 265–270.Jayaratnam A., Corrigan C.J., Lee T.H. The continuing enigma of non-atopic asthma. Clin. Exp. Allergy 2005; 35 (7): 835–837.Jayaratnam A., Corrigan C.J., Lee T.H. The continuing enigma of non-atopic asthma. Clin. Exp. Allergy 2005; 35 (7): 835–837.Bachert C., Gevaert P., van Cauwenberge P. Staphylococcus aureus enterotoxins: a key in airway disease? Allergy 2002; 57 (6): 480–487.Bachert C., Gevaert P., van Cauwenberge P. Staphylococcus aureus enterotoxins: a key in airway disease? Allergy 2002; 57 (6): 480–487.Штерншис Ю.А., Самойликов П.В., Червинская Т.А., Гервазиева В.Б. Влияние вирусных инфекций на уровень общего IgE при бронхиальной астме и атопическом дерматите. Рос. аллергол. журн. 2004; 3: 32–36.Штерншис Ю.А., Самойликов П.В., Червинская Т.А., Гервазиева В.Б. Влияние вирусных инфекций на уровень общего IgE при бронхиальной астме и атопическом дерматите. Рос. аллергол. журн. 2004; 3: 32–36.Штерншис Ю.А., Лизогуб Н.В., Кривицкая В.З., Гервазиева В.Б. Острые респираторно-вирусные инфекции и бронхиальная астма. Инфекц. бол. 2006; 4 (3): 18–21.Штерншис Ю.А., Лизогуб Н.В., Кривицкая В.З., Гервазиева В.Б. Острые респираторно-вирусные инфекции и бронхиальная астма. Инфекц. бол. 2006; 4 (3): 18–21.Чучалин А.Г., Оспельникова Т.П., Осипова Г.Л. и др. Роль респираторных инфекций в обострениях бронхиальной астмы. Пульмонология 2007; 5: 14–18.Чучалин А.Г., Оспельникова Т.П., Осипова Г.Л. и др. Роль респираторных инфекций в обострениях бронхиальной астмы. Пульмонология 2007; 5: 14–18.Ten Brinke A., van Dissel J.T., Sterk P.J. et al. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J. Allergy Clin. Immunol. 2001; 107 (3): 449–454.Ten Brinke A., van Dissel J.T., Sterk P.J. et al. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J. Allergy Clin. Immunol. 2001; 107 (3): 449–454.Раковская И.В., Горина Л.Г., Утюшева М.Г. и др. Инфицированность микоплазмами детей, больных бронхиальной астмой. Журн. микробиол. 2006; 4: 78–81.Раковская И.В., Горина Л.Г., Утюшева М.Г. и др. Инфицированность микоплазмами детей, больных бронхиальной астмой. Журн. микробиол. 2006; 4: 78–81.Atassi M.Z., Casali P. Molecular mechanisms of autoimmunity. Autoimmunity 2008; 41 (2): 123–132.Atassi M.Z., Casali P. Molecular mechanisms of autoimmunity. Autoimmunity 2008; 41 (2): 123–132.Braun7Fahrlander C., Riedler J., Herz U. et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 2002; 347: 869–877.Braun7Fahrlander C., Riedler J., Herz U. et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 2002; 347: 869–877.Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology. 2004; 112: 352–363.Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology. 2004; 112: 352–363.Romagnani S. Coming back to a missing immune deviation as the main explanatory mechanism for the hygiene hypothesis. J. Allergy Clin. Immunol. 2007; 119: 1511–1513.Romagnani S. Coming back to a missing immune deviation as the main explanatory mechanism for the hygiene hypothesis. J. Allergy Clin. Immunol. 2007; 119: 1511–1513.Caffarelli C., Cavagni G., Pierdomenico R. et al. Coexistence of IgE-mediated allergy and Type 1 diabetes in childhood. Int. Arch. Allergy Immunol. 2004; 134 (4): 288–294.Caffarelli C., Cavagni G., Pierdomenico R. et al. Coexistence of IgE-mediated allergy and Type 1 diabetes in childhood. Int. Arch. Allergy Immunol. 2004; 134 (4): 288–294.Tirosh A., Mandel D., Mimouni F.B. et al. Autoimmune diseases in asthma. Ann. Intern. Med. 2006; 144 (12): 877–883.Tirosh A., Mandel D., Mimouni F.B. et al. Autoimmune diseases in asthma. Ann. Intern. Med. 2006; 144 (12): 877–883.Kero J., Gissler M., Hemminki E., Isolauri E. Could Th1 and Th2 diseases coexist? Evaluation of asthma incidence in children with celiac disease, Type 1 diabetes, or rheumatoid arthritis: a register study. J. Allergy Clin. Immunol. 2001; 108 (5): 781–783.Kero J., Gissler M., Hemminki E., Isolauri E. Could Th1 and Th2 diseases coexist? Evaluation of asthma incidence in children with celiac disease, Type 1 diabetes, or rheumatoid arthritis: a register study. J. Allergy Clin. Immunol. 2001; 108 (5): 781–783.Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133: 775–787.Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133: 775–787.Roncarolo M.G., Gregori S., Battaglia M. et al. Interleukin10-secreting type 1 regulatory T cells in rodent and humans. Immunol. Rev. 2006; 212: 28–50.Roncarolo M.G., Gregori S., Battaglia M. et al. Interleukin10-secreting type 1 regulatory T cells in rodent and humans. Immunol. Rev. 2006; 212: 28–50.Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of cell-mediated tissue damage. Nature Med. 2007; 13: 139–145.Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of cell-mediated tissue damage. Nature Med. 2007; 13: 139–145.Alcorn J.F., Crowe Ch.R., Kolls J.K. Th17 cells in Asthma and COPD. Ann. Rev. Physiol. 2010; 72: 495–516.Alcorn J.F., Crowe Ch.R., Kolls J.K. Th17 cells in Asthma and COPD. Ann. Rev. Physiol. 2010; 72: 495–516.Saito H. Essentials for starting a pediatric clinical study (2): Role of environment and immunity in the development of childhood allergic and immunologic disorders. J. Toxicol. Sci. 2009; 34 (Suppl. 2): S313–S319.Saito H. Essentials for starting a pediatric clinical study (2): Role of environment and immunity in the development of childhood allergic and immunologic disorders. J. Toxicol. Sci. 2009; 34 (Suppl. 2): S313–S319.Tan C., Gery I. The unique features of Th9 cells and their products. Crit. Rev. Immunol. 2012; 32 (1): 1–10.Tan C., Gery I. The unique features of Th9 cells and their products. Crit. Rev. Immunol. 2012; 32 (1): 1–10.

The authors declare that there are no conflicts of interest present.